Nα-Fmoc-Nε-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-lysine
Need Assistance?
  • US & Canada:
    +
  • UK: +

Nα-Fmoc-Nε-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-lysine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

The amino-protecting group Dde is orthogonal to both Fmoc and Boc protection and therefore useful to enable extension from lysine side chains by using Fmoc-tBu solid-phase methodologies.

Category
Fmoc-Amino Acids
Catalog number
BAT-003699
CAS number
150629-67-7
Molecular Formula
C31H36N2O6
Molecular Weight
532.58
Nα-Fmoc-Nε-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-lysine
IUPAC Name
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]hexanoic acid
Synonyms
Fmoc-L-Lys(Dde)-OH; (S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-6-((1-(4,4-DIMETHYL-2,6-DIOXOCYCLOHEXYLIDENE)ETHYL)AMINO)HEXANOIC ACID
Appearance
Yellowish to off-white powder
Purity
≥ 99.5% (Chiral HPLC)
Density
1.222±0.06 g/cm3(Predicted)
Melting Point
126-136 °C
Boiling Point
750.1±60.0 °C(Predicted)
Storage
Store at 2-8°C
InChI
InChI=1S/C31H36N2O6/c1-19(28-26(34)16-31(2,3)17-27(28)35)32-15-9-8-14-25(29(36)37)33-30(38)39-18-24-22-12-6-4-10-20(22)21-11-5-7-13-23(21)24/h4-7,10-13,24-25,32H,8-9,14-18H2,1-3H3,(H,33,38)(H,36,37)/t25-/m0/s1
InChI Key
ZPSRBXWVBNVFTO-VWLOTQADSA-N
Canonical SMILES
CC(=C1C(=O)CC(CC1=O)(C)C)NCCCCC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
1.Strategies for the synthesis of labeled peptides.
Bibbs L1, Ambulos NP, Kates SA, Khatri A, Medzihradszky KF, Osapay G, Weintraub ST. J Biomol Tech. 2000 Dec;11(4):155-65.
Labeled peptides synthesized by core facilities are frequently used by researchers for following trafficking of a peptide, for binding studies, to determine substrate specificity, and for receptor cross-linking studies.The membership of the Association of Biomolecular Resource Facilities was asked to participate in a study focusing on synthesis of a biotin-labeled peptide, and it was suggested that a new strategy, using Rink amide 4-methylbenzhydrylamine resin coupled with Fmoc-Lys(Dde)-OH, be used.This strategy can be used for addition of a variety of labels other than biotin and should prove useful to core facilities. Comparison of the new strategy to other strategies was performed. Biotin labeling has long been assumed to be routine and specific. Despite the assumed routine nature of synthesizing biotinylated peptides, 9 of the 34 samples submitted did not contain any of the correct product. Although synthesis using Fmoc-Lys(Dde)-OH plus biotin generally gave the highest yields, other approaches also yielded a high percentage of the correct product.
Online Inquiry
Verification code
Inquiry Basket